---
title: "ClinDataBench: Evaluating LLM Agents for CDISC ADaM Dataset Construction"
id: "medrxiv-15-clindatabench-benchmarking-large-language-model-agents-in-clinical-trial"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-15-clindatabench-benchmarking-large-language-model-agents-in-clinical-trial"
content_type: "clinical_feed_article"
specialty: "Pharmacology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.11.17.26368316v1?rss=1"
published_at: "2026-11-19T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# ClinDataBench: Evaluating LLM Agents for CDISC ADaM Dataset Construction
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-15-clindatabench-benchmarking-large-language-model-agents-in-clinical-trial
- **Specialty:** [Pharmacology](https://medichelpline.com/clinical-feed/pharmacology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.11.17.26368316v1?rss=1)
- **Published At:** 2026-11-19T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The authors built **ClinDataBench**, a benchmark that tasks LLM-based coding agents with producing complete, conformant clinical analysis packages from public trial inputs. - Input materials supplied to each agent included 22 **SDTM** domains, a statistical analysis plan (SAP), and dataset specifications; required outputs were 13 **ADaM** datasets, Define-XML metadata and a reproducible program. - Agents executed in isolated containers whose only network access was a model API; agents could reference published reference outputs only through that API during runs. - The evaluator used a host-only pipeline that measured P21 validator conformance, selected derivation correctness, ability to cleanly reconstruct outputs, and human effort as separate axes. - Three workflow settings were compared: Base (first submission), Self-Refine (iterative revision without validator feedback), and CRITIC (revision with the agent’s own validator report). - In an exploratory pilot the study team ran six models. Three closed-weight models and DeepSeek produced all 13 datasets in every setting; two open-weight models produced no complete package. - Validator findings per package ranged from 15 to 64 dataset-rule pairs; four of six CRITIC workflows produced usable validator comparisons and all reduced their finding counts. - Semantic reconstruction succeeded for eleven of twelve packages from the top-performing agents, but none of the workflows reduced the count of failed derivations. - The package with the fewest validator findings still omitted the 234 efficacy summary records in the specifications’ required form, indicating fewer validator errors do not guarantee correct derivations. - Data and code for the benchmark are available in the ClinDataBench repository; the de-identified trial inputs come from the CDISC SDTM/ADaM Pilot Project. - The preprint is not peer-reviewed; full run artifacts were not publicly distributed by the authors.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=0nNP3S5dSaBZKeKEcbHNo9sZ1DG9rkw6EJls6hYowwg-1795158996.4750032-1.2.1.1-kIeOu3KoXqS50RQkKOChbFuJGKnQZl0Q7vAf8qn3ub2Ew.Dhm_zyX2RVd8t7NRRx) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.11.17.26368316v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # ClinDataBench: Benchmarking Large Language Model Agents in Clinical Trial Analysis Dataset Construction Zeyu Li, Yichen Luo, Yebo Feng, Jiahua Xu doi: https://doi.org/10.64898/2026.11.17.26368316 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Zeyu Li 1 Georgia Institute of Technology; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Zeyu%2BLi%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Li%20Z&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AZeyu%2BLi%2B) Yichen Luo 2 The University of Hong Kong; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Yichen%2BLuo%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Luo%20Y&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AYichen%2BLuo%2B) * For correspondence: yichen.luo.22@ucl.ac.uk Yebo Feng 3 Nanyang Technological University; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Yebo%2BFeng%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Feng%20Y&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AYebo%2BFeng%2B) Jiahua Xu 4 University College London * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jiahua%2BXu%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Xu%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJiahua%2BXu%2B) * [Abstract](https://www.medrxiv.org/content/10.64898/2026.11.17.26368316v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1349275/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.11.17.26368316v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1349275/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.11.17.26368316v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1349275/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.11.17.26368316v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1349275/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.11.17.26368316v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1349275/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract A new drug reaches patients only after the U.S. Food and Drug Administration (FDA) has reviewed its trial evidence, which every application carries as analysis datasets in the Clinical Data Interchange Standards Consortium (CDISC) Analysis Data Model (ADaM) format that programmers derive by hand from raw trial data, a statistical analysis plan (SAP) and dataset specifications. Coding agents built on large language models (LLMs) could take over this work, and a slow-changing industry will adopt them only with evidence of what they get right and wrong. However, work on large language models (LLMs) for CDISC data stops short of evaluating a complete, conformant and reproducible package, and the standard validator checks structure rather than whether each value is derived correctly. We introduce ClinDataBench, built on the public CDISC pilot study: an agent receives 22 Study Data Tabulation Model (SDTM) domains, the statistical analysis plan (SAP) and specifications, and must deliver 13 Analysis Data Model (ADaM) datasets, Define-XML metadata and a program that rebuilds them offline. Agents run in containers whose only network route is their model API, restricting online access to published reference outputs during execution. A host-only evaluator scores conformance under the Pinnacle 21 Community (P21) validator, selected derivations, clean reconstruction and effort separately. We compare three settings: Base, which submits the agent's first package; Self-Refine, which revises it without external validation feedback; and CRITIC, which revises it with the agent's own validator report. In an exploratory pilot with six models, the three closed models and DeepSeek delivered all 13 datasets in every setting and eleven of their twelve packages rebuilt semantically, while two other open-weight models delivered no complete package. Validator findings ranged from 15 to 64 dataset-rule pairs. Four of six CRITIC workflows had usable validator comparisons, and each reduced its finding count. None reduced its failed derivation count. The package with the fewest findings carried none of the 234 efficacy summary records in the form the specifications define, showing that lower validator finding counts do not necessarily indicate more correct derivations. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: This study used only de-identified human clinical trial data that were openly available to the public before the study began. The data were obtained from the CDISC SDTM/ADaM Pilot Project: https://github.com/cdisc-org/sdtm-adam-pilot-project. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability The de-identified source clinical trial data are publicly available from the CDISC SDTM/ADaM Pilot Project (https://github.com/cdisc-org/sdtm-adam-pilot-project). The benchmark harness, evaluator, and aggregate experimental results are available in the ClinDataBench repository (https://github.com/lyc0603/clinical_bench). Full run artifacts are not publicly distributed. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.11.17.26368316v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.11.17.26368356v1 "Understanding oral PrEP uptake and persistence among gay men and other men who have sex with men in Cape Town, South Africa: Perspectives of clients and providers")[Next ](https://www.medrxiv.org/content/10.64898/2026.11.17.26368305v1 "ProbeFit: one-seizure qualification and personalisation of multimodal wearable seizure detectors") Posted November 19, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.11.17.26368316v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/11/19/2026.11.17.26368316.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.11.17.26368316v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/11/19/2026.11.17.26368316.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) ClinDataBench: Benchmarking Large Language Model Agents in Clinical Trial Analysis Dataset Construction Zeyu Li, Yichen Luo, Yebo Feng, Jiahua Xu medRxiv 2026.11.17.26368316; doi: https://doi.org/10.64898/2026.11.17.26368316 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.17.26368316v1%26text%3DClinDataBench%253A%2520Benchmarking%2520Large%2520Language%2520Model%2520Agents%2520in%2520Clinical%2520Trial%2520Analysis%2520Dataset%2520Construction "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.17.26368316v1%26t%3DClinDataBench%253A%2520Benchmarking%2520Large%2520Language%2520Model%2520Agents%2520in%2520Clinical%2520Trial%2520Analysis%2520Dataset%2520Construction "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.17.26368316v1%26title%3DClinDataBench%253A%2520Benchmarking%2520Large%2520Language%2520Model%2520Agents%2520in%2520Clinical%2520Trial%2520Analysis%2520Dataset%2520Construction%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.17.26368316v1%26title%3DClinDataBench%253A%2520Benchmarking%2520Large%2520Language%2520Model%2520Agents%2520in%2520Clinical%2520Trial%2520Analysis%2520Dataset%2520Construction "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.11.17.26368316) Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (642) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (927) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (355) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (5055) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (496) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (432) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (681) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1703) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (16339) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (37) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1248) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7326) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (759) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1100) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5344) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1480) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1846) * [Hematology](https://www.medrxiv.org/collection/hematology) (603) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1389) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16534) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1209) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (702) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (157) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (756) * [Neurology](https://www.medrxiv.org/collection/neurology) (7656) * [Nursing](https://www.medrxiv.org/collection/nursing) (380) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1142) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1306) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1045) * [Oncology](https://www.medrxiv.org/collection/oncology) (3765) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1105) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (413) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (473) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (506) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (144) * [Pathology](https://www.medrxiv.org/collection/pathology) (726) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1876) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (758) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (791) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (6183) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (10045) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2558) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1537) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1280) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (666) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (812) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (601) * [Surgery](https://www.medrxiv.org/collection/surgery) (809) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (109) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (321) * [Urology](https://www.medrxiv.org/collection/urology) (309) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been transferred to the new platform using the medRxiv_admin account. Please read our [commenting guide](https://connect.biorxiv.org/news/2022/03/21/commenting_on_preprints) for more information. Share this comments tab (click to copy link)Copied! TRiP medRxiv partners with journals and review services to enable posting of peer reviews and editorial decisions related to preprints they are evaluating. Reviews are posted with the consent of the authors. TRiP reviews are part of a peer review pilot project in which participating organizations post peer reviews of manuscripts they are evaluating _There is no TRiP material for this paper._ Community Reviews medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Community reviews for this article: _There are no community reviews for this paper._ Automated Evaluations Certain services provide automated analysis of preprints. Analyses invited by the authors are displayed at the top of this tab. Those done independently of authors are shown underneath . None of these analyses is endorsed by medRxiv. Automated Evaluations: _There are no automated evaluations for this paper._ Blog/Media Links medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Video medRxiv partners with conferences and institutions to display recordings of talks and seminars related to preprints. These are posted with the consent of the authors. Video: _There are no videos for this paper._ Powered by
## Related Clinical Research

- [Allergens in glucose monitoring systems identified by validated GC-MS; evidence of a 'sponge effec](https://medichelpline.com/clinical-feed/pubmed-42887950.md) (DOI: 10.1016/j.aca.2026.346179)
- [Bisphenol A in follicular fluid and associations with oocyte maturation and embryo arrest in IVF](https://medichelpline.com/clinical-feed/pubmed-43062947.md) (DOI: 10.1080/09513590.2026.2766634)
- [Big Pharma: AI halves early drug-discovery timelines; companies avoid Xinjiang trial sites](https://medichelpline.com/clinical-feed/stat-news-0-stat-pharmalittle-we-re-reading-about-sanofi-eyeing-insmed-ai-speeding-drug.md)
- [ITE-Transformer: Pretrained model for individualized treatment effects from EHRs](https://medichelpline.com/clinical-feed/medrxiv-17-the-ite-transformer-a-pre-trained-foundation-model-for-predicting.md)
- [How countries adapt the WHO Model List of Essential Medicines: alignment versus expansion](https://medichelpline.com/clinical-feed/medrxiv-22-alignment-and-expansion-in-national-adaptation-of-the-who-model-list-of.md)

## Navigation
- [← Back to Pharmacology Feed](https://medichelpline.com/clinical-feed/pharmacology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.